Get exclusive money-saving offers and guides
Straight to your inbox
By signing up, you agree to the Finder
Privacy & Cookies Policy
and
Terms of Use, Disclaimer & Privacy Policy.
How to buy Probiotec shares
Own Probiotec shares in just a few minutes.
Updated
Fact checked
Investments
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Probiotec Limited is a drug manufacturers—specialty & generic business based in Australia. Probiotec shares (PBP) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Probiotec has a trailing 12-month revenue of around $107.2 million..
How to buy shares in Probiotec
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Probiotec . Find the share by name or ticker symbol: PBP. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Probiotec reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price of $1.795, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Probiotec . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
US stocks
Finder Award
Our top pick for
Cheap broker fees
Finder Award
Our top pick for
Long-term investing
Finder Award
🧪How we chose these brokers
For our Top Picks, we compared our Finder partners using a proprietary algorithm in August 2020. Keep in mind that our top picks may not always be the best for you, and you're encouraged to compare for yourself to find one that works for you. Read our full methodology here to find out more.Probiotec share price
Use our graph to track the performance of PBP stocks over time.Probiotec shares at a glance
Information last updated 2020-10-20.
| 52-week range | $1.55 - $2.48 |
|---|---|
| 50-day moving average | $1.7922 |
| 200-day moving average | $1.9057 |
| Target price | N/A |
| PE ratio | 18.6006 |
| Dividend yield | $0.04 (2.52%) |
| Earnings per share (TTM) | $0.05 |
Share Trading Account Offer
IG Share Trading Offer
AUD 8
Standard brokerage - Australian shares
Share Trading Account Offer
Competitive broker fees on Australian and international shares
- Brokerage - AU shares: From AUD 5 or 0.05%
- Brokerage - US shares: USD 0
- Sign-up process: Instant
- Support - After hours: Yes
More info
Important: Share trading carries risk of capital loss.
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy Probiotec stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Probiotec price performance over time
Historical closes compared with the close of A$1.795 on 2020-10-22
| 1 week (2021-01-15) | -27.62% |
|---|---|
| 1 month (2020-12-23) | -21.62% |
| 3 months (2020-10-23) | 3.16% |
| 6 months (2020-07-23) | -10.25% |
| 1 year (2020-01-23) | -19.87% |
|---|---|
| 2 years (2019-01-23) | 19.67% |
| 3 years (2018-01-23) | 106.32% |
| 5 years (2016-01-22) | 322.35% |
Is Probiotec under- or over-valued?
Valuing Probiotec stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Probiotec 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Probiotec 's P/E ratio
Probiotec 's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 19x. In other words, Probiotec shares trade at around 19x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Probiotec 's EBITDA
Probiotec 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14 million (ÂŁ0.0 million).
The EBITDA is a measure of a Probiotec 's overall financial performance and is widely used to measure a its profitability.
Probiotec financials
| Revenue TTM | $107.2 million |
|---|---|
| Operating margin TTM | 10.1% |
| Gross profit TTM | $31.8 million |
| Return on assets TTM | 5.63% |
| Return on equity TTM | 11.68% |
| Profit margin | 3.27% |
| Book value | 0.809 |
| Market capitalisation | $134.6 million |
TTM: trailing 12 months
Probiotec share dividends
Dividend payout ratio: 44.44% of net profits
Recently Probiotec has paid out, on average, around 44.44% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.52% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Probiotec shareholders could enjoy a 2.52% return on their shares, in the form of dividend payments. In Probiotec 's case, that would currently equate to about A$0.04 per share.
While Probiotec 's payout ratio might seem fairly standard, it's worth remembering that Probiotec may be investing much of the rest of its net profits in future growth.
The latest dividend was paid out to all shareholders who bought their shares by 22 October 2020 (the "ex-dividend date").
Probiotec share price volatility
Over the last 12 months, Probiotec 's shares have ranged in value from as little as $1.55 up to $2.48. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Probiotec 's is 0.2863. This would suggest that Probiotec 's shares are less volatile than average (for this exchange).
Probiotec overview
Probiotec Limited engages in the development, manufacture and sale of pharmaceuticals, consumer health, and nutraceutical products in Australia and internationally. The company provides contract manufacturing services for solid dose tablets, capsules, and caplets; tablets coating; blister packing; liquids, creams, gels, and ointments and suspensions; powders and powder blending; and sprays, as well as manufacturing and packaging of finished doses. It also offers analytical and stability testing services; new product formulation and production trials, and ongoing research and development services; and packaging options for human and animal nutrition products, as well as manufactures and exports a range of nutraceuticals and functional ingredient raw materials. In addition, the company provides packing services and formats, including foil, carded and clamshell blister packing, bottle filling, labelling, secondary packaging, and other services for the pharmaceutical, cosmetic, and food industries. Probiotec Limited was incorporated in 1996 and is headquartered in Laverton North, Australia.
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
Best moisturiser for dry skin in Australia
From the best overall face moisturiser for dry skin to the best body moisturiser, hand moisturiser and tinted moisturiser for dry skin, these are the best 7 moisturisers for dry skin you can buy in Australia right now.
-
Best RC planes in Australia
From the best RC plane for beginners to the top model for aerial photography, these are the six best RC planes in Australia right now.
-
How to buy Probiotec units | A$51.65
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
-
How to buy Probiotec units | A$52.8
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
-
How to buy Probiotec units | A$104.04
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
-
How to buy Probiotec units | A$24.04
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
-
How to buy Probiotec units | A$89.5
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
-
How to buy Probiotec units | A$16.94
Steps to owning and managing ETFS FANG+ ETF units.
-
How to buy Probiotec units | A$73.79
Steps to owning and managing ETFS S&P Biotech ETF units.
-
How to buy Probiotec units | A$51.56
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Ask an Expert
